Principal Investigator of the study will join Pluristem management to announce results at the Tel Aviv Stock Exchange
HAIFA, ISRAEL, January 06, 2014 — Pluristem Therapeutics Inc. (NasdaqCM: PSTI; TASE: PLTR), today announced that the results of the company’s Phase I/II clinical trial testing the safety and efficacy of PLacental Expanded (PLX-PAD) cells for the treatment of muscle injury will be presented on January 21, 2014.
The Principal Investigator of the study will join Pluristem’s management to discuss these results as part of Pluristem’s Regenerative Medicine Day to be held on the above date at the Tel Aviv Stock Exchange, Tel Aviv Israel.
This randomized, placebo-controlled, double blinded study was conducted at the Ortho- pedic Clinic on the campus of the Charité University Medical School under the auspices of the Paul-Ehrlich-Institute (PEI), Germany’s health authority. The injured muscle stud- ied was the gluteal buttock muscle that has been surgically traumatized during total hip replacement surgery.
The study was comprised of 3 treatment groups, two PLX-PAD groups of different doses and one placebo group. The primary endpoints of the study include safety and the maxi- mal contraction force of the gluteal muscle at six months post-surgery. The secondary efficacy endpoints include an analysis of the macrostructure and microstructure of the gluteal muscle using magnetic resonance imaging (MRI) and biopsy.
“We look forward to receiving the results from this important orthopedic study. Data from this clinical trial will give us information regarding other potential surgical orthope- dic injuries and non-surgical sports related injuries for which our PLX-PAD cells may be beneficial,” stated Zami Aberman, Chairman and CEO of Pluristem. “This Phase I/II study marked the first time PLX-PAD cells were used to address surgically induced mus- cle injury.”
Pluristem Therapeutics Inc. is a leading developer of placenta-based cell therapies. The Company’s patented PLX (PLacental eXpanded) cells are a drug delivery platform that releases a cocktail of therapeutic proteins in response to a host of local and systemic in-flammatory and ischemic diseases. PLX cells are grown using the company’s proprietary 3D micro-environmental technology and are an “off-the-shelf” product that requires no tissue matching prior to administration.
Pluristem has a strong intellectual property position, company-owned GMP certified manufacturing and research facilities, strategic relationships with major research institu- tions and a seasoned management team. For more information visit www.pluristem.com, the content of which is not part of this press release.
This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and federal securities laws. For example, when we discuss receiving and announcing the result of our Phase I/II muscle injury trial, we are using forward-looking statements. These forward-looking statements and their impli- cations are based on the current expectations of the management of Pluristem only, and are sub- ject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. The following factors, among others, could cause actual results to differ materially from those described in the forward-looking state- ments: changes in technology and market requirements; we may encounter delays or obstacles in launching and/or successfully completing our clinical trials; our products may not be approved by regulatory agencies, our technology may not be validated as we progress further and our methods may not be accepted by the scientific community; we may be unable to retain or attract key em- ployees whose knowledge is essential to the development of our products; unforeseen scientific difficulties may develop with our process; our products may wind up being more expensive than we anticipate; results in the laboratory may not translate to equally good results in real surgical settings; results of preclinical studies may not correlate with the results of human clinical trials; our patents may not be sufficient; our products may harm recipients; changes in legislation; ina- bility to timely develop and introduce new technologies, products and applications; loss of market share and pressure on pricing resulting from competition, which could cause the actual results or performance of Pluristem to differ materially from those contemplated in such forward-looking statements. Except as otherwise required by law, Pluristem undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. For a more detailed descrip- tion of the risks and uncertainties affecting Pluristem, reference is made to Pluristem’s reports filed from time to time with the Securities and Exchange Commission.
Contact:
Pluristem Therapeutics Inc.:
Karine Kleinhaus, MD, MPH Director of Investor Relations 1-914-512-4109
Daya Lettvin
Investor & Media Relations Director
+972-54-674-5580
Terms of use
Use of the
Pluri Web Site
General
Pluri
Biotech Ltd., on its behalf and on behalf of its related companies, including
without limitations, its parent company, Pluri Inc. (collectively: “Pluri”)
maintains [https://www.pluri-biotech.com/] (this “Website”) for
informational purposes in favor of the Internet community. Access to and use of
information presented on this Website is subject to the following terms and
conditions which may be revised at any time by Pluri and to the Privacy Notice
located on this Website and incorporated hereto by reference.
The
information contained in these pages is not intended to provide medical advice,
recommendation or instruction on the appropriate use of Pluri’s technology, nor
that Pluri technology is marketable nor fit for a particular purpose. In
addition, nothing herein shall be deemed as solicitation for purchasing any of Pluri’s
securities.
Please
read carefully the following terms and conditions. The use of this Website is
governed by these terms and conditions and our Privacy Policy, By using and accessing this Website, you
agree to be bound by these terms of use including any amendments that may be
made by Pluri from time to time at its sole discretion. Pluri encourages the
users of this Website to periodically review these terms of use for any changes
or amendments.
Forward-Looking
Statements; SEC / TASE Filings
Pluri
Inc., is a public company, which securities are traded on the Tel Aviv Stock
Exchange (TASE) and Nasdaq. Statements on this Website regarding Pluri’s
business which are not historical facts are “forward-looking statements” within
the meaning of the “safe harbor” provisions of the Private Securities
Litigation Reform Act of 1995 and federal securities laws, that involve risks
and uncertainties. Forward-looking statements can be identified by, among other
things, the use of forward-looking language, such as “anticipate”, “believe”,
“could”, “estimate”, “expect”, “future”, “intend”, “plan”, “potential”, and may
describe opinions about future events. These forward-looking statements are
based on the current expectations of the management of Pluri only, and are
subject to a number of factors and uncertainties that could cause actual
results to differ materially from those described in the forward-looking
statements. The following factors, among others, could cause actual results to
differ materially from those described in the forward-looking statements:
changes in technology and market requirements; we may encounter delays or
obstacles in launching our clinical trials; our technology may not be validated
as we progress further and our methods may not be accepted by the scientific
community; we may be unable to retain or attract key employees whose knowledge
is essential to the development of our products; unforeseen scientific
difficulties may develop with our progress; our products may wind up being more
expensive than we anticipate; results in the laboratory may not translate to
equally good results in real surgical settings; our patents may not be
sufficient; our products may harm recipients; changes in legislation; inability
to timely develop and introduce new technologies, products and applications;
loss of market share and pressure on pricing resulting from competition, which
could cause the actual results or performance of Pluri to differ materially
from those contemplated in such forward-looking statements. For a more detailed
description of the risks and uncertainties affecting Pluri, reference is made
to Pluri’s reports filed from time to time with the Securities and Exchange
Commission (“SEC”). Pluri disclaims any intention or obligation to update or
revise any forward-looking statements, whether as a result of new information,
future events or otherwise. No information or statement in this website is
intended to solicit in any manner whatsoever any person to purchase or deal in
any securities of Pluri. Pluri may provide links to its filings with the SEC
for informational purposes only, and not for trading or investment purposes. Pluri
does not guarantee the sequence, accuracy or completeness of any information or
data displayed through these links. Pluri does not assume any duty of
disclosure and expressly disclaims any duty to update information set forth in
its filings with the SEC. The stock price performance shown on stock
quotes may be available on or through this Website is not necessarily
indicative of future price performance. All content is for informational
purposes only and no content is intended to be relied upon for trading or
investment purposes. Nothing on this website constitutes an invitation or offer
to invest or deal in the securities of Pluri. In particular, actual results and
developments may be substantially and materially different from any opinion or
forecast expressed on this website.
Links
to Third Party Websites
The
Website may provide links to World Wide Web sites or resources. Because Pluri
has no control over such sites and resources, you acknowledge and agree that Pluri
is not responsible for the availability of such external sites or resources,
and does not endorse and is not responsible or liable for any information,
advertising, products, or other materials on or available from such sites or
resources. You further acknowledge and agree that Pluri shall not be
responsible or liable, directly or indirectly, for any damage or loss caused or
alleged to be caused by or in connection with use of or reliance on any such
information, goods or services available on or through any such site or
resource.
Conduct
Within
the course of your use of the Website you will strictly adhere with the
following policies, such that, you must not:
·
Scan or use this Website via operation of
a computer program designed to gather information or perform operations
imitating a human user (including, without limitation, Bots or Crawlers);
·
Manipulate the architecture of this
Website, or otherwise gain access to any of its engines and/or databases to
which we did not provide you with an expressly permitted access (including,
without limitation, URL Hacking);
·
Carry out any action which may infringe
the copyrights and/or any other proprietary information of ours or any other
copyright holder;
·
Copy, transmit, decompile, modify, create
derivative works, reproduce, disassemble, republish, scrape, and/or reverse
engineer (including any extraction of the work process) any algorithm, code,
syntax and/or any other content associated with this Website and/or any
components thereof and/or act to collect, harvest and/or data mine any data
associated with the Website and/or any of its users (whether by computer
programs, identity theft, impersonation, or otherwise) and/or take any action
which may be deemed as impersonating another person or entity, identity theft,
etc.;
·
Carry out any action which may infringe
any laws, regulations, orders or any guidelines of any governmental authority,
is likely to offend or harm any other users of this Website and/or the general
public;
·
Steal or attempt to steal private
information from other users of this Website;
·
Email us content which is or could be
considered libelous, defamatory, indecent, vulgar, obscene, pornographic,
sexually explicit or suggestive, racially or ethically offensive, harmful,
harassing, intimidating, threatening, discriminatory, or abusive;
·
Carry out any action that violates these
Terms, Privacy Notice and/or any other guidelines or policies as prescribed
herein and/or as otherwise published by us from time to time.
·
Assist, encourage or enable others to do
any of the preceding prohibited activities.
Intellectual
Property Rights
You
acknowledge that Pluri owns all copyrights in the information, selection,
coordination, arrangement and enhancement of this Website, which may contain
information, software, photos, video, text, graphics, or other material posted
or uploaded by Pluri (collectively, the “Pluri Content”), and that these rights
are valid and protected in all forms, media and technologies existing now or
here after developed. Pluri has the full rights and authorization to use this
Website’s name and logo. You may not modify, publish, transmit, participate in
the transfer or sell, create derivative works, or in any way exploit, any of
the Pluri Content, in whole or in part. Modification of the Pluri Content or
use of any Pluri Content on any other website, networked computer environment
or elsewhere is strictly prohibited. The Pluri Content is subject to copyright
protection. You may not copy the contents of this Website other than for
non-commercial individual reference with all copyright or other proprietary
notices retained, and thereafter the contents may not be recopied, reproduced
or otherwise redistributed. You may not distribute, modify, repost, copy,
publish license or use the contents of this website, including information,
photos, video, text, graphics or other material posted or upload by Pluri
for public or commercial purposes. Some of the tradenames or trademarks used in
this Website are registered trademarks of Pluri and/or its affiliates. The use
or misuse of any of these trademarks or unregistered trademarks or any other
materials, except as permitted herein, is expressly prohibited and may result,
inter alia, in violation of copyright laws and trademark laws.
Subject
to any applicable terms and conditions set forth in our Privacy Notice, any
communication or other material that you send to us through the Internet or
post on the Website by electronic mail or otherwise, such as any questions,
comments, suggestions or the like, is and will be deemed to be non-confidential
and we shall have no obligation of any kind with respect to such information. Pluri
shall be free to use any ideas, concepts, know-how or techniques contained in
such communication for any purpose whatsoever, including but not limited to,
developing, manufacturing and marketing products.
Disclaimers
THE
INFORMATION AND/OR STATEMENTS PROVIDED ON THIS WEBSITE ARE PROVIDED ‘AS IS’ AND
FOR NO COST AND YOU MAY USE IT AT YOUR SOLE RISK. PLURI EXPRESSLY DISCLAIMS ALL
WARRANTIES OF ANY KIND, WHETHER EXPRESS OR IMPLIED, INCLUDING, BUT NOT LIMITED
TO THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE
AND NON-INFRINGEMENT. WITHOUT LIMITATION, PLURI MAKES NO WARRANTY THAT THIS
WEBSITE AND/OR THE INFORMATION PROVIDED THEREIN WILL MEET YOUR REQUIREMENTS,
THAT IT WILL BE UNINTERRUPTED, TIMELY, SECURE, OR ERROR-FREE, THAT THE RESULTS
OBTAINED FROM THE USE OF THIS WEBSITE WILL BE ACCURATE OR RELIABLE, OR THAT THE
QUALITY OF ANY INFORMATION OR OTHER MATERIAL OBTAINED THROUGH THIS WEBSITE WILL
MEET YOUR EXPECTATIONS. ANY MATERIAL DOWNLOADED OR OTHERWISE OBTAINED THROUGH
THE USE OF THIS WEBSITE IS DONE AT YOUR SOLE RISK AND YOU WILL BE SOLELY
RESPONSIBLE FOR ANY DAMAGE TO YOUR COMPUTER SYSTEM OR LOSS OF DATA THAT RESULTS
FROM THE DOWNLOAD OF ANY SUCH MATERIAL.
Limitation
of Liability
YOU
EXPRESSLY UNDERSTAND AND AGREE THAT PLURI INCLUDING ITS OFFICERS, DIRECTORS,
SHAREHOLDERS, EMPLOYEES, SUB-CONTRACTORS AND AGENTS SHALL NOT BE LIABLE FOR ANY
DIRECT, INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL OR EXEMPLARY DAMAGES,
INCLUDING BUT NOT LIMITED TO, DAMAGES FOR LOSS OF PROFITS, GOODWILL, USE, DATA
OR OTHER INTANGIBLE LOSSES (EVEN IF PLURI HAS BEEN ADVISED OF THE POSSIBILITY
OF SUCH DAMAGES), RESULTING FROM THE USE OF OR THE INABILITY TO USE THIS
WEBSITE AND/OR INFORMATION PROVIDED THEREIN. SOME JURISDICTIONS DO NOT ALLOW
THE EXCLUSION OF CERTAIN WARRANTIES OR THE LIMITATION OR EXCLUSION OF LIABILITY
FOR INCIDENTAL OR CONSEQUENTIAL DAMAGES. ACCORDINGLY, SOME OF THE ABOVE
LIMITATIONS MAY NOT APPLY TO YOU.
WITHOUT
DEROGATING FROM THE GENERAL NATURE OF THE FOREGOING, WE ASSUME NO LIABILITY FOR
ANY DAMAGES CAUSED BY VIRUSES, WORMS AND/OR OTHER MALICIOUS SOFTWARE WHICH MAY
INFECT THE USER’S MACHINE(S).
Indemnification
You
agree to indemnify, defend and hold harmless Pluri, its officers, directors,
shareholders, employees, sub-contractors, affiliates, agents and anyone acting
on their behalf, at your own expense and immediately after receiving a written
notice from Pluri, from and against any damages, loss, costs, expenses and
payments, including reasonable attorney’s fees and legal expenses, resulting
from any complaint, claim, or demand, arising from or related to your breach of
these terms of use, or any other terms, rules or regulations applicable to this
website, or your violation, or infringement of other persons rights.
Miscellaneous
Governing
Law. These terms of use shall be governed in accordance with the laws of the
State of Israel without giving effect to any conflicts of law principles. Any
dispute in connection with these terms of use shall be submitted to the
exclusive jurisdiction of the competent courts situated in Tel Aviv, Israel.
Entire
Agreement. These terms and conditions contain the entire agreement between the
parties with respect to the subject matter hereof, and supersede all prior and
contemporaneous representations, promises, agreements and understandings,
whether oral or written, between the parties concerning the subject matter
hereof.
Severability.
If any provision of these terms of use shall be deemed to be invalid, void,
illegal or for any reason unenforceable, that term or condition shall be deemed
severable and shall not affect the validity and enforceability of the remaining
terms set forth herein. Subject to any applicable law, all disputes between you
and us shall only be resolved on an individual basis and you shall not have the
right to bring any claim against us as a plaintiff or a member of a class,
consolidated or representative actions (or any other legal proceedings
conducted by a group or by representatives on behalf of others).
Assignment.
You may not assign any rights and/or obligations you may have under these terms
and conditions and/or Privacy Notice without our prior written consent. We may
freely assign any of its rights and/or obligations herein, without limitations;
provided that, your rights herein shall not be adversely affected.
Change
of Control. It is clarified that in the event of a merger, change of control
and/or any similar transaction involving Pluri, Pluri may transfer and export
all information it may have gained through the course of the use of the
Website, and your use of this Website constitutes as consent for the foregoing;
provided however, that any such transfer shall be subject to applicable data
privacy requirements and standards.
Amendment.
Pluri reserves the right to amend or revise any of these terms of use. Any such
change or amendment shall be updated on this Website.
The
content, text, graphics, data, and services offered herein are provided solely
to educate users of this Website on Pluri and the goods and/or services it may
provide. Nothing in said content should be considered, or used as a
substitute for, medical advice, diagnosis or treatment. Always seek the
advice of your physician or other qualified health provider with any questions you
may have regarding a medical condition. Reliance on said content or any
portion thereof, or other visitors to the web site, is solely at your own risk.
If
you have cause to believe any content found on the Platform to be in violation
of these terms and conditions and/or infringe any third party proprietary
rights and/or applicable law, kindly notify us of such content via email
to info@pluri-biotech.com, stating the violating
content and the nature of violation.
Physical address: Matam Park, Building 05, Haifa, 3508409, Israel
Accessibility
Accessibility Statement
Pluri Biotech Ltd. is committed to making its electronic and information technologies accessible to individuals with disabilities by meeting or exceeding the requirements of the Web Content Accessibility Guidelines and we make every effort to ensure our communications – including this website – are accessible to people with special needs.
We have striven to make this website adhere to priority 1 and 2 guidelines of the W3 Web Content Accessibility Guidelines.
Navigation and navigation aids
Help with finding content
Although we do our best to meet the requirements and guidelines, it is possible that some of the content is not yet fully accessible and compatible to people with special needs.
We continue to develop and improve our website as part of our general commitment to make every effort to ensure our communications are accessible to all.
If you require assistance or wish to report an issue related to the accessibility of any content on this website, please contact info@pluri-biotech.com. If applicable, please include the web address or URL and the specific problems you have encountered.
Pluri – Privacy Policy
Last updated on 26 December 2022
Pluri Biotech Ltd., on its behalf and on behalf of its related companies (“Pluri” “we” or “us”) respects the privacy of its participants, employees, sites visitors and website visitors (these and any others with respect to whom we collect personal data, shall collectively be referred to as “you” or “Data Subjects”) and is committed to protecting the personal information you may share with us.
This policy and notice (the “Privacy Policy”) explains the types of information we may collect from you, that we may receive about you or that you may provide during your participation in our services, business transactions, conferences or when you visit our sites or website. We are transparent about our practices regarding the information we may collect, use, maintain and process and describe our practices in this Privacy Policy. Please read the following carefully to understand our practices regarding your personal data and how we will treat it.
What is Personal Data?
Regarding our relations with you in connection with your use of our services, “Personal Data” means any data, which may enable the identification of a specific person, or is otherwise linked to such potentially identifying data.
We will use your Personal Data to provide and improve our services to our participants and others and meet our contractual, ethical and legal obligations. All Personal Data will remain accurate complete and relevant for the stated purposes for which it was processed, including for example:
Processing which is necessary for the performance of a contract to which you are a party or in order to take steps at your request prior to entering into a contract:
Processing which is necessary for the purposes of the legitimate interests pursued by Pluri:
Processing which is necessary for compliance with a legal obligation to which Pluri is subject:
Non-Personal Data. We may share or otherwise use non-Personal Data in our sole discretion and without the need for further approval.
We collect two main categories of Personal Data:
If you choose to give us your e-mail address, we will communicate with you via e-mail. We do not share your e-mail address with other individuals, entities and/or parties outside of Pluri. Depending on how your email application is set up, information about your actions, use of the email sent by us, may be transmitted automatically when you receive, open and/ or click on an e-mail from Pluri. In any event, you may opt out from receipt of any additional e-mails from Pluri, at any time.
When you access or use our services or website, Pluri may use industry standard technologies such as cookies, pixels and similar technologies, which store certain information on your computer or browsing device and which will allow us to identify the computer or device and, in some cases, to identify them with the user, and to enable automatic activation of certain features, and make your user experience more convenient and effortless. We use different types of cookies: some cookies are strictly necessary, they are required for the operation of our website and services under our terms with you; We also use analytical and performance monitoring cookies, which allow us to recognize and count the number of visitors and to see how visitors move around our website and services when they are using it. Finally, we use functionality cookies which are used to recognize you when you return to our website. This enables us to personalize content to your preferences, including for example, your choice of language or region.
Different cookies are kept for different periods. Session cookies are used to keep track of your activities online in a given browsing session; these cookies generally expire when the browser is closed but may be retained for a period on your device. Permanent cookies remain in operation even when you have closed the browser; they are used to remember your login details and password. Third-party cookies are installed by third parties with the aim of collecting certain information to research behavior, demographics. Third party cookies on our site include, for example, Google Analytics. Likewise, pixels from Youtube and others enable integration of third-party service providers may be embedded on our site. Third party cookies will be retained according to the terms of those third parties, and you can control those cookies in your browser settings.
We use cookies and other technologies on the basis that they are necessary for the performance of a contract with you, or because using them is in our legitimate interests of improving, optimizing and personalizing our services, and these are not overridden by your rights.
Most browsers will allow you to erase cookies from your computer’s hard drive, block acceptance of cookies, or receive a warning before a cookie is stored. However, if you block or erase cookies your online experience on our websites and services will be limited.
How to disable cookies: the effect of disabling cookies depends on which cookies you disable but, in general, the websites and some services delivered through them may not operate properly, may not recognize your device, may not remember your preferences and so on, if cookies are disabled or removed. However, allowing or disabling cookies is your choice and in your control. If you want to disable cookies on our site, you need to change your browser settings to reject cookies. How you can do this will depend on the browser you use. Further details on how to disable cookies can be found here: Microsoft Edge, Google Chrome, Firefox, Safari.
Pluri Biotech Ltd. is located and operates under the jurisdiction of the State of Israel, which has been declared by the European Commission, on the basis of Article 45 of Regulation (EU) 2016/679 as a country outside the European Union (the “EU”) which offers an adequate level of data protection.
Company’s parent, Pluri Therapeutics Inc. is a Nevada-based corporation, and thus abides by the applicable U.S. privacy law; however, it has also taken upon itself, to adopt additional security measures regarding the storage of your Personal Data, and only to use it in accordance with this Privacy Policy.
While privacy laws may vary between jurisdictions, Pluri has taken reasonable steps to ensure that your Personal Data is treated by its affiliates and Service Providers in a secure and lawful manner, and in accordance with common industry practices, regardless of any lesser legal requirements that may apply in their jurisdiction.
Pluri retains Personal Data it processes only for as long as required in our view, to provide the services and as necessary to comply with our legal and other obligations, to resolve disputes and to enforce agreements. We will also retain personal data to meet any audit, compliance and business best-practices.
Data that is no longer retained may be anonymized or deleted. Likewise, some metadata and statistical information concerning the use of our services are not subject to the deletion procedures in this policy and may be retained by Pluri. We will not be able to identify you from this data. Some data may also be retained on our third-party service providers’ servers until deleted in accordance with their privacy policy and their retention policy.
Please note that except as required by applicable law, we will not be obligated to retain your data for any particular period, and are free to securely delete it for any reason and at any time, with or without notice to you.
We may share your data (including Personal Data) with certain third parties, including law enforcement agencies, our service providers, and our affiliates – but only in accordance with this Privacy Policy:
Pluri maintains physical, electronic and procedural safeguards to help guard your Personal Data. We restrict access to personally identifiable information to those persons who need to know that information to provide products or services to you and any persons you have authorized to have access to such information. While we strive to protect your Personal Data, we cannot guaranty the security of any information you transmit to us.
Pluri shall act in accordance with its policies and with applicable law to promptly notify the relevant authorities and data subjects in the event that any Personal Data processed by Pluri is lost, stolen, or where there has been any unauthorized access to it, all in accordance with applicable law and on the instructions of qualified authority. Pluri shall promptly take reasonable remedial measures.
We may allow access to your Personal Data for the uses prescribed in this Privacy Policy, internally, between our group entities. In instances where Personal Data is collected from individuals within the EU, we will make sure that for the transfer outside EU borders (a) an EU Commission Adequacy Decision is in place, or (b) we have a legitimate interest of such transfer, and the recipient entity is bound by similar security measures that we apply, and further subject to the provisions of Section 5.
Please note that you may have certain rights regarding the manner of collection, processing and usage of your Personal Data pursuant to applicable privacy laws such as the EU General Data Protection Regulations (“GDPR”). Under the GDPR (to the extent it applies to you) you may be eligible for the following rights:
Please note that the above list contains a summary of the main rights you may have under the GDPR. Under no circumstances shall the above be deemed as an exhaustive list, nor should you rely on it in terms of fully understanding all of your rights under the GDPR.
Additional Information for users entitled to rights under GDPR:
EU Representative. Our European representative, for the purposes of this Privacy Policy, is Pluri GmbH. If you are within the European Economic Area, you may contact our European representative at the following address: Brentanoweg 9, 14469 Potsdam, Germany, or by email address: dataprotection@Pluri.com
If you believe your right have been infringed, you can lodge a complaint with a supervisory authority operating under the GDPR. For a list of supervisory authorities in the EU, click here.
This website is directed towards and designed for use by persons aged 18 and older. We do not solicit or knowingly collect Personal Data from children under the age of 18. If we nevertheless receive Personal Data from an individual who indicates that he or she is, or whom we otherwise have reason to believe is, under the age of 18, we will delete such information from our systems.
The website may contain links to other websites. While we try to link only to websites that share our respect for privacy, please be aware that Pluri is not responsible for the privacy practices or the content of other websites. Websites that are accessible by hyperlinks from our website may use cookies. We encourage you to read the privacy statements provided by other websites before you provide personally identifiable information to them.
This Privacy Policy may change over time as we modify or expand our service. If we decide to change our Privacy Policy, we will prominently post those changes on this page. Your continued use of this website after we post such notice constitutes your agreement to any such changes.
If you have any questions about this Privacy Policy, or in the event that you wish to exercise certain rights you are eligible for with respect to your Personal Data, please contact us via the below online contact form. We welcome your questions and suggestions about our Privacy Policy.
Contact Information:
By mail: info@pluri-biotech.com; dataprotection@pluri-biotech.com
(Kindly state the nature of your inquiry at the subject line of the email)
Physical address:
Pluri Biotech Ltd.
Attention: General Counsel and DPO
Matam Park, Building 05
Haifa, 3508409, Israel
©2023 Pluri™ Inc., its logo, brand, product, and process names appearing in this issue are the trademarks of Pluri™ Inc. or its affiliated companies. All other brand, product, and process names appearing are the trademarks of their respective holders. Reference to or use of a product, or process other than those of Pluri™ Inc. does not imply recommendation, approval, affiliation, or sponsorship of that product, or process by Pluri™ Inc. Nothing contained herein shall be construed as conferring by implication, estoppel, or otherwise any license or right under any patent, copyright, trademark, or other intellectual property right of Pluri™ Inc. or any third party, except as expressly granted herein. All information herein is for general information only and is subject for change without notice.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.